HEMEX
As a swiss investment and consulting company headquartered close to the Basel global life sciences hub, our main focus is to bring innovative drugs, medical devices and in vitro diagnostics to the market. We specialize in supporting start-ups. Working closely with your management team, we offer tailored solutions to accelerate your project into a successful and sustainable business. Our team of life science, legal and financial professionals covers a wide range of expertise. From development... support like preclinical/clinical trial management, regulatory affairs, quality assurance, CMC and medical affairs, to business coaching, marketing strategy, intellectual property creating and finding financing solutions, we know how to successfully bring a product from the lab to the market. Our offices in Switzerland, Germany and USA work closely with local health authorities, patient groups, contract research organizations and key opinion leaders.
HEMEX
Social Links:
Industry:
Angel Investment Life Science Medical Device Pharmaceutical
Founded:
2015-05-29
Status:
Active
Contact:
+41 61 927 28 00
Email Addresses:
[email protected]
Total Funding:
109.73 K USD
Technology used in webpage:
SPF Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving IPv6 ReCAPTCHA JsDelivr AJAX Libraries API BootstrapCDN
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Hubertus Apotheke am Salzufer
Hubertus Apotheke am Salzufer offers you a wide range of pharmaceuticals and medical devices.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Current Advisors List
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-26 | Hemotune | Hemex investment in Series B - Hemotune | 7.25 M CHF |
| 2020-06-09 | Scailyte | Hemex investment in Seed Round - Scailyte | 3.1 M CHF |
| 2020-04-09 | Annaida Technologies | Hemex investment in Seed Round - Annaida Technologies | 1000 K CHF |
| 2019-12-17 | Resistell AG | Hemex investment in Series A - Resistell AG | 3.5 M CHF |
| 2019-06-07 | Annaida Technologies | Hemex investment in Pre Seed Round - Annaida Technologies | 140 K CHF |
| 2019-05-29 | Sleepiz | Hemex investment in Seed Round - Sleepiz | 1.04 M CHF |
| 2019-05-22 | BioReperia | Hemex investment in Series A - BioReperia | 8 M SEK |
| 2019-04-11 | Nuomedis | Hemex investment in Venture Round - Nuomedis | 2.7 M CHF |
| 2018-12-19 | Scailyte | Hemex investment in Seed Round - Scailyte | 3.5 M CHF |
| 2018-12-09 | Resistell AG | Hemex investment in Seed Round - Resistell AG | 750 K CHF |